SOCIETY FOR IMMUNOTHERAPY OF CANCER INC, of MILWAUKEE, WI, is a Public Charity tracked in Imperigo's IRS 990 database. The 2024 filing shows $12.8M in revenue, $14.1M in expenses, $21.9M in total assets. 11 publicly reported grants to this organization, totaling roughly $391K, appear in IRS filings.
TO IMPROVE CANCER PATIENT OUTCOMES BY ADVANCING THE SCIENCE, DEVELOPMENT AND APPLICATION OF CANCER IMMUNOLOGY AND IMMUNOTHERAPY THROUGH OUR CORE VALUES OF INTERACTION/INTEGRATION, INNOVATION, TRANSLATION, DIVERSITY AND INCLUSION AND LEADERSHIP IN THE FIELD. SITC AIMS TO MAKE CANCER IMMUNOTHERAPY A STANDARD OF CARE AND THE WORD "CURE" A REALITY FOR CANCER PATIENTS EVERYWHERE.
How Society for Immunotherapy of Cancer Inc divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
Plus 1 more program. Cost per person served and the full program breakdown are on the full profile.
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Showing up to 5 of 11 total records — full history available with membership.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $12.8M | $14.1M | $21.9M |
| 2023 | $15.2M | $15.3M | $22.5M |
| 2022 | $17.2M | $14.2M | $24.3M |
| 2020 | $6.6M | $8.1M | $16.8M |
| 2019 | $13.9M | $11.1M | $17.5M |
Between 2019 and 2024, reported annual revenue declined from $13.9M to $12.8M (-8%), with total assets most recently reported at $21.9M.
Interactive year-over-year charts and full filing details available with membership.
